VLV-IL-12p35

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVLV-IL-12p35
Drug Alias NameVLVIL-12-p-35
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionCell death stimulantsInterleukin-12 receptor stimulantsHelper-inducer T-lymphocytes stimulants
TargetsInterleukin-12 receptor
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A